{
  "guideline": {
    "id": "PA166104976",
    "name": "Annotation of DPWG Guideline for paroxetine and CYP2D6",
    "source": "DPWG",
    "version": 34,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166104976",
    "relatedChemicals": [
      {
        "id": "PA450801",
        "name": "paroxetine",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA128",
        "name": "cytochrome P450 family 2 subfamily D member 6",
        "symbol": "CYP2D6"
      }
    ],
    "recommendation": true
  },
  "recommendations": [
    {
      "id": "PA166302559",
      "name": "Recommendation Annotation PA166302559",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104138,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The plasma concentration of paroxetine can increase as a result of the reduced activity of CYP2D6. However, studies did not find any clinical effects."
      ],
      "lookupKey": {
        "CYP2D6": "0.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302581",
      "name": "Recommendation Annotation PA166302581",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104180,
        "html": "<p>It is not possible to offer substantiated advice for dose adjustment based on the literature.</p>\n<p>Avoid paroxetine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include for example citalopram or sertraline.</p>\n"
      },
      "implications": [
        "Efficacy will probably be lacking. The genetic variation increases the conversion of paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302603",
      "name": "Recommendation Annotation PA166302603",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104202,
        "html": "<p>It is not possible to offer substantiated advice for dose adjustment based on the literature.</p>\n<p>Avoid paroxetine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include for example citalopram or sertraline.</p>\n"
      },
      "implications": [
        "Efficacy will probably be lacking. The genetic variation increases the conversion of paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "≥3.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302563",
      "name": "Recommendation Annotation PA166302563",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104142,
        "html": "<p>The guideline does not provide a recommendation for paroxetine in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "1.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302558",
      "name": "Recommendation Annotation PA166302558",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104137,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The plasma concentration of paroxetine can increase as a result of the reduced activity of CYP2D6. However, studies did not find any clinical effects."
      ],
      "lookupKey": {
        "CYP2D6": "0.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302602",
      "name": "Recommendation Annotation PA166302602",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104201,
        "html": "<p>It is not possible to offer substantiated advice for dose adjustment based on the literature.</p>\n<p>Avoid paroxetine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include for example citalopram or sertraline.</p>\n"
      },
      "implications": [
        "Efficacy will probably be lacking. The genetic variation increases the conversion of paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "≥3.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302562",
      "name": "Recommendation Annotation PA166302562",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104141,
        "html": "<p>The guideline does not provide a recommendation for paroxetine in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on paroxetine"
      ],
      "lookupKey": {
        "CYP2D6": "1.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302606",
      "name": "Recommendation Annotation PA166302606",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104205,
        "html": "<p>It is not possible to offer substantiated advice for dose adjustment based on the literature.</p>\n<p>Avoid paroxetine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include for example citalopram or sertraline.</p>\n"
      },
      "implications": [
        "Efficacy will probably be lacking. The genetic variation increases the conversion of paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "≥6.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302566",
      "name": "Recommendation Annotation PA166302566",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104145,
        "html": "<p>The guideline does not provide a recommendation for paroxetine in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "2.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302557",
      "name": "Recommendation Annotation PA166302557",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104136,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The plasma concentration of paroxetine can increase as a result of the reduced activity of CYP2D6. However, studies did not find any clinical effects."
      ],
      "lookupKey": {
        "CYP2D6": "0.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302601",
      "name": "Recommendation Annotation PA166302601",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104200,
        "html": "<p>It is not possible to offer substantiated advice for dose adjustment based on the literature.</p>\n<p>Avoid paroxetine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include for example citalopram or sertraline.</p>\n"
      },
      "implications": [
        "Efficacy will probably be lacking. The genetic variation increases the conversion of paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "≥3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302561",
      "name": "Recommendation Annotation PA166302561",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104140,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The plasma concentration of paroxetine can increase as a result of the reduced activity of CYP2D6. However, studies did not find any clinical effects."
      ],
      "lookupKey": {
        "CYP2D6": "1.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302605",
      "name": "Recommendation Annotation PA166302605",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104204,
        "html": "<p>It is not possible to offer substantiated advice for dose adjustment based on the literature.</p>\n<p>Avoid paroxetine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include for example citalopram or sertraline.</p>\n"
      },
      "implications": [
        "Efficacy will probably be lacking. The genetic variation increases the conversion of paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "≥5.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302565",
      "name": "Recommendation Annotation PA166302565",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104144,
        "html": "<p>The guideline does not provide a recommendation for paroxetine in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "2.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302582",
      "name": "Recommendation Annotation PA166302582",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104181,
        "html": "<p>It is not possible to offer substantiated advice for dose adjustment based on the literature.</p>\n<p>Avoid paroxetine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include for example citalopram or sertraline.</p>\n"
      },
      "implications": [
        "Efficacy will probably be lacking. The genetic variation increases the conversion of paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302560",
      "name": "Recommendation Annotation PA166302560",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104139,
        "html": "<p>NO action is needed for this gene-drug interaction.</p>\n"
      },
      "implications": [
        "The plasma concentration of paroxetine can increase as a result of the reduced activity of CYP2D6. However, studies did not find any clinical effects."
      ],
      "lookupKey": {
        "CYP2D6": "0.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302604",
      "name": "Recommendation Annotation PA166302604",
      "population": null,
      "classification": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104203,
        "html": "<p>It is not possible to offer substantiated advice for dose adjustment based on the literature.</p>\n<p>Avoid paroxetine. Antidepressants that are not metabolised by CYP2D6, or to a lesser extent, include for example citalopram or sertraline.</p>\n"
      },
      "implications": [
        "Efficacy will probably be lacking. The genetic variation increases the conversion of paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "≥4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166302564",
      "name": "Recommendation Annotation PA166302564",
      "population": null,
      "classification": {
        "term": "No recommendation",
        "termId": "guidelineStrength:1448526251"
      },
      "relatedChemicals": [
        {
          "id": "PA450801",
          "name": "paroxetine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452104143,
        "html": "<p>The guideline does not provide a recommendation for paroxetine in normal metabolizers.</p>\n"
      },
      "implications": [
        "The guideline does not provide a description of the impact of a normal metabolizer phenotype on paroxetine."
      ],
      "lookupKey": {
        "CYP2D6": "2.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": "34782755",
      "title": "Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.",
      "authors": [
        "Brouwer Jurriaan M J L",
        "Nijenhuis Marga",
        "Soree Bianca",
        "Guchelaar Henk-Jan",
        "Swen Jesse J",
        "van Schaik Ron H N",
        "Weide Jan van der",
        "Rongen Gerard A P J M",
        "Buunk Anne-Marie",
        "de Boer-Veger Nienke J",
        "Houwink Elisa J F",
        "van Westrhenen Roos",
        "Wilffert Bob",
        "Deneer Vera H M",
        "Mulder Hans"
      ],
      "journal": "European journal of human genetics : EJHG",
      "year": 2022,
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/34782755"
    },
    {
      "pmid": "21412232",
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2011,
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21412232"
    }
  ],
  "version": "2024-02-29-20-19"
}